Core Viewpoint - The article highlights the internationalization strategy upgrade of iFlytek and iFlytek Medical, marking the launch of their global strategy with Hong Kong as a key hub for their artificial intelligence applications [2][3]. Group 1: Internationalization Strategy - iFlytek and iFlytek Medical have officially launched their international headquarters and research institute in Hong Kong, aiming to leverage the city's advantages as an innovation and technology hub [4][5]. - The companies have introduced Hong Kong and international versions of their AI products across various sectors, including healthcare, education, and office applications, based on the iFlytek Spark large model [4][6]. Group 2: Collaboration and Development - iFlytek plans to deepen collaborations with local universities and institutions in Hong Kong to enhance technology exchange and application expansion, targeting markets in Southeast Asia and along the Belt and Road [5][6]. - The Hong Kong government supports the establishment of iFlytek's international headquarters, which aligns with the local innovation and technology development direction, particularly in smart healthcare [6]. Group 3: Achievements and Impact - iFlytek Medical has successfully listed on the Hong Kong Stock Exchange, becoming the first medical large model stock in the market and included in the Hang Seng Composite Index [6]. - The establishment of iFlytek in Cyberport has contributed to the local AI ecosystem, with Cyberport housing over 2,200 companies, including 400 focused on AI and data science [6].